799 related articles for article (PubMed ID: 31731051)
1. Proteomic investigation on bio-corona of Au, Ag and Fe nanoparticles for the discovery of triple negative breast cancer serum protein biomarkers.
Del Pilar Chantada-Vázquez M; López AC; Vence MG; Vázquez-Estévez S; Acea-Nebril B; Calatayud DG; Jardiel T; Bravo SB; Núñez C
J Proteomics; 2020 Feb; 212():103581. PubMed ID: 31731051
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of the bio-corona formed on the surface of (Au, Ag, Pt)-nanoparticles in human serum.
Del Pilar Chantada-Vázquez M; López AC; Bravo SB; Vázquez-Estévez S; Acea-Nebril B; Núñez C
Colloids Surf B Biointerfaces; 2019 May; 177():141-148. PubMed ID: 30721790
[TBL] [Abstract][Full Text] [Related]
3. Protein Corona Gold Nanoparticles Fingerprinting Reveals a Profile of Blood Coagulation Proteins in the Serum of HER2-Overexpressing Breast Cancer Patients.
Chantada-Vázquez MDP; Castro López A; García-Vence M; Acea-Nebril B; Bravo SB; Núñez C
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182810
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic significance of serum apolipoprotein C-I in triple-negative breast cancer based on mass spectrometry.
Song D; Yue L; Zhang J; Ma S; Zhao W; Guo F; Fan Y; Yang H; Liu Q; Zhang D; Xia Z; Qin P; Jia J; Yue M; Yu J; Zheng S; Yang F; Wang J
Cancer Biol Ther; 2016 Jun; 17(6):635-47. PubMed ID: 27260686
[TBL] [Abstract][Full Text] [Related]
5. How eluents define proteomic fingerprinting of protein corona on nanoparticles.
Qiu L; Zhang Y; Wei G; Wang C; Zhu Y; Yang T; Chu Z; Gao P; Cheng G; Ma A; Kwan Wong Y; Zhang J; Xu C; Wang J; Tang H
J Colloid Interface Sci; 2023 Oct; 648():497-510. PubMed ID: 37307606
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the differences of serum protein mass spectrometry in patients with triple negative breast cancer and non-triple negative breast cancer.
Liu AN; Sun P; Liu JN; Yu CY; Qu HJ; Jiao AH; Zhang LM
Tumour Biol; 2014 Oct; 35(10):9751-7. PubMed ID: 24972967
[TBL] [Abstract][Full Text] [Related]
7. Triple Negative Breast Cancer Detection Using LC-MS/MS Lipidomic Profiling.
Eghlimi R; Shi X; Hrovat J; Xi B; Gu H
J Proteome Res; 2020 Jun; 19(6):2367-2378. PubMed ID: 32397718
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of intracellular protein corona of nanoparticles elucidates nano-trafficking network and nano-bio interactions.
Qin M; Zhang J; Li M; Yang D; Liu D; Song S; Fu J; Zhang H; Dai W; Wang X; Wang Y; He B; Zhang Q
Theranostics; 2020; 10(3):1213-1229. PubMed ID: 31938061
[TBL] [Abstract][Full Text] [Related]
9. Quantitative proteomics reveals stage-specific protein regulation of triple negative breast cancer.
Lin Y; Lin L; Fu F; Wang C; Hu A; Xie J; Jiang M; Wang Z; Yang L; Guo R; Yang P; Shen H
Breast Cancer Res Treat; 2021 Jan; 185(1):39-52. PubMed ID: 32920739
[TBL] [Abstract][Full Text] [Related]
10. LC-MS/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer.
Gong S; Wang Q; Huang J; Huang R; Chen S; Cheng X; Liu L; Dai X; Zhong Y; Fan C; Liao Z
Methods; 2024 Feb; 222():100-111. PubMed ID: 38228196
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Profile of Neutrophil-Derived Granule Proteins in the Surface of Gold Nanoparticles after Their Interaction with Human Breast Cancer Sera.
Chantada-Vázquez MDP; García-Vence M; Vázquez-Estévez S; Bravo SB; Núñez C
Nanomaterials (Basel); 2020 Jun; 10(6):. PubMed ID: 32586001
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomic profiling of triple-negative breast cancer reveals that up-regulation of RhoGDI-2 is associated to the inhibition of caspase 3 and caspase 9.
Muñiz Lino MA; Palacios-Rodríguez Y; Rodríguez-Cuevas S; Bautista-Piña V; Marchat LA; Ruíz-García E; Astudillo-de la Vega H; González-Santiago AE; Flores-Pérez A; Díaz-Chávez J; Carlos-Reyes Á; Álvarez-Sánchez E; López-Camarillo C
J Proteomics; 2014 Dec; 111():198-211. PubMed ID: 24768906
[TBL] [Abstract][Full Text] [Related]
13. Mass spectrometric approach for the analysis of the hard protein corona of nanoparticles in living cells.
Szekeres GP; Fernández-Iglesias N; Kneipp J; Montes-Bayón M; Bettmer J
J Proteomics; 2020 Feb; 212():103582. PubMed ID: 31731052
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
[TBL] [Abstract][Full Text] [Related]
15. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
[TBL] [Abstract][Full Text] [Related]
16. Interaction of gold and silver nanoparticles with human plasma: Analysis of protein corona reveals specific binding patterns.
Lai W; Wang Q; Li L; Hu Z; Chen J; Fang Q
Colloids Surf B Biointerfaces; 2017 Apr; 152():317-325. PubMed ID: 28131092
[TBL] [Abstract][Full Text] [Related]
17. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
18. Serum lncRNA TINCR Serve as a Novel Biomarker for Predicting the Prognosis in Triple-Negative Breast Cancer.
Wang X; Li S; Xiao H; Deng X
Technol Cancer Res Treat; 2020; 19():1533033820965574. PubMed ID: 33084530
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Proteomic Technologies for Blood-Based Detection of Colorectal Cancer.
Bhardwaj M; Terzer T; Schrotz-King P; Brenner H
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530402
[TBL] [Abstract][Full Text] [Related]
20. Protein corona as a proteome fingerprint: The example of hidden biomarkers for cow mastitis.
Miotto G; Magro M; Terzo M; Zaccarin M; Da Dalt L; Bonaiuto E; Baratella D; Gabai G; Vianello F
Colloids Surf B Biointerfaces; 2016 Apr; 140():40-49. PubMed ID: 26735893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
